Article Dans Une Revue Therapies Année : 2024

Characteristics of patients who are initiated on long-acting buprenorphine (Buvidal®) in France: A retrospective cross-sectional study

Résumé

The long-acting buprenorphine Buvidal ® is a recent type of opioid agonist treatment (OAT) used for opioid use disorder (OUD). It was initially suggested to preferentially use Buvidal ® for specific OUD populations, including people in prison, or patients in recovery and on sublingual

Fichier principal
Vignette du fichier
Characteristics of patients who are initiated on long-acting buprenorphine (Buvidal®) in France= A retrospective cross-sectional study.pdf (477) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
licence

Dates et versions

hal-04908685 , version 1 (23-01-2025)

Licence

Identifiants

Citer

Alice Deschenau, Benoit Trojak, Georges Brousse, Lisa Blecha, Julien Azuar, et al.. Characteristics of patients who are initiated on long-acting buprenorphine (Buvidal®) in France: A retrospective cross-sectional study. Therapies, 2024, ⟨10.1016/j.therap.2024.09.003⟩. ⟨hal-04908685⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More